baCta
Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Developing diagnostics and therapies targeting infectious diseases and the microbiome.
Infectious DiseaseDiagnosticsMicrobiome
Technology Platform
An integrated platform combining rapid pathogen diagnostics with therapeutic development targeting specific bacteria and microbiome restoration.
Opportunities
Addressing the critical global health threat of antimicrobial resistance with a combined diagnostic and therapeutic solution.
Risk Factors
Regulatory and reimbursement hurdles for new diagnostic tests, and the scientific complexity of effectively modulating the human microbiome.
Competitive Landscape
Faces competition from large diagnostic companies (like bioMérieux) and numerous startups in the rapidly evolving microbiome and AMR spaces.